| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Halogen Network is a San Francisco, CA-based company in the Software & Internet sector.
Truthset is a data intelligence company focused exclusively on validating the accuracy of consumer data. Truthset helps companies build trust in data, and improve the performance of any data-driven decision.
Quotech is a company that creates insurance technology applications which make data fueled processes dramatically more efficient for commercial underwriters and brokers.
11:11 is invested in creating a new model delivering the power of “Everything Connected” for its customers and partners. Fully integrated, fully automated. All services, all activities, all data, all performance, powered on a single platform.